PHARMACOKINETICS LIMITS CLINICAL USE OF IVERMECTIN FOR COVID-19 - 21DOCS Test Area

AUTHOREA

Log in Sign Up Browse Preprints

LOG IN SIGN UP

loading page

this is for holding javascript data

Download ZIP
Download LaTeX
Download JATS XML
Track citations
Fork (make a copy)

1,101

37

PHARMACOKINETICS LIMITS CLINICAL USE OF IVERMECTIN FOR COVID-19

Ricardo Pena Silva,
Sandra Jaramillo Rincon

Ricardo Pena Silva

Universidad de los Andes

Corresponding Author:[email protected]

Sandra Jaramillo Rincon

Universidad de los Andes

21DOCS Test Area

| Powered by Authorea.com

Home
Lorem Ipsum Article Five
About 21DOCS